COVID-19: Expert committee recommends restricted emergency...

New Delhi [India], January 2 (ANI): The Subject Expert Committee (SEC) of Central Drugs Standards Control...

Expert panel recommends restricted emergency use nod to...

New Delhi [India], January 2 (ANI): An expert panel of Drugs Controller General of India (DCGI) has recommended...

COVID-19: Health ministry decides not to put Itolizumab in...

New Delhi, July 26 (ANI): Even as the Drugs Controller General of India (DCGI) has given permission to Itolizumab...

COVID-19: DCGI nod to Jubilant Generics to manufacture, sell...

New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma...

DCGI approves Itolizumab injection for restricted emergency...

New Delhi [India], July 11 (ANI): The Drug Controller General of India (DCGI) granted its permission to...

DCGI gives nod to Mylan labs to manufacture remdesivir for...

New Delhi [India], July 2 (ANI): The Drug Controller General of India (DCGI) has granted permission to Mylan...

Domestic pharma giants-- Cipla, Hetero got DCGI's nod to...

New Delhi [India], June 21 (ANI): In a significant development, India's top drug regulator has given nod to two...

Anti-viral drug favipiravir gets DGCI nod for 'restricted...

New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral...

Remdesivir included in 'investigational therapy' for...

New Delhi [India], June 14 (ANI): Union Health Ministry on Sunday said that drug Remdesivir has been included as an...

India to soon begin domestic production of Remdesivir drug to...

New Delhi [India], June 13 (ANI): India is soon going to have its domestic production of anti-viral Remdesivir drug,...

Restricted, emergency use of Remdesivir, Tocilizumab likely...

New Delhi [India], June 11 (ANI): Remdesivir, an antiviral drug and Tocilizumab, an immunomodulator, are being...

COVID-19: Remdesivir gets nod from CDCSO for 'restricted...

New Delhi [India], June 2 (ANI): In a significant development, the country's top drug controller the Central Drug...